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Despite its previous classification as a gammaherpesvirus, primarily due to its lymphotropism, Marek's disease virus (MDV), 
an oncogenic avian herpesvirus, is phylogenetically more related to the "neurotropic" alphaherpesviruses, characterized by 
its prototype, herpes simplex virus (HSV) (Buckmaster et aL, 1988, J. Gen. ViroL 69, 2033-2042). In this report we present 
the DNA sequence of an 11,286-bp DNA segment encompassing the entire 11,160-bp-long Us region of the oncogenic avian 
herpesvirus, Marek's disease virus. Eleven open reading frames (ORFs) likely to code for proteins were identified; of these, 
7 represent homologs exclusive to alphaherpesvirus S component genes. These include MDV counterparts of HSV US1 
(ICP22), US2, US3 (a serine-threonine protein kinase), US6, US7, and US8 (HSV glycoproteins gD, gl, and gE, respectively), 
and US10. Three additional ORFs were identified with no apparent relation to any sequences currently present in the 
SwissProt or GenBank/EMBL databases, while a fourth was found to exhibit significant homology to an uncharacterized 
fowlpox virus (FPV) ORF. Having precisely identified the IRs-Us and Us-TRs junctions, we have corrected and clarified their 
previously reported locations. By characterizing enes encoding three new alphaherpesvirus-related homologs (US1, US8, 
and US10), completing the sequence for a fourth (US7), and identifying 2 new MDV-specific ORFs (SORF1 and SORF3) and 
a fowlpox homolog (SORF2), our sequence analysis of the "virulent" GA strain of MDV (vMDV) extends upon that of a 5255- 
bp segment located in the Us region of the "very virulent" RBIB strain of MDV (vvMDV) (Ross et aL, 1991, J. Gen. ViroL 72, 
939-947; 949-954). These two sequences were found to exhibit 99% identity at both nucleotide and predicted amino acid 
levels. Combined with the fact that MDV Us sequences failed to show statistically significant CpG deficiencies, our analysis 
is consistent with MDV bearing a closer phylogenetic relation to alphaherpesviruses than to gammaherpesviruses. Because 
alphaherpesvirus-specific Us region genes are primarily nonessential for virus replication, they are thought to be important 
biological property determinants. Thus, our sequence provides a foundation for further MDV studies aimed at resolving the 
apparent discrepancy between MDV's genetic and biologic properties. © 1995 Academic Press, Inc. 
INTRODUCTION 
Marek's disease virus (MDV) is a highly pathogenic 
herpesvirus of chickens, which can cause= (i) T-cell 
lymphomas as early as 3 weeks postinfection; (ii) periph- 
eral neural lesions, characterized by lymphoproliferative 
infiltration and demyelination, occasionally leading to pa- 
ralysis and/or blindness; (iii) various phenomena of ac- 
quired immunodeficiency; and (iv) atherosclerosis in nor- 
mocholesterolemic hickens, bearing a remarkable re- 
semblance to the human disease, in both character and 
distribution of arterial lesions (reviewed in Calnek and 
Witter, 1991). Marek's disease (MD) most commonly re- 
fers to the lymphoproliferative conditions above and is 
noteworthy for being the first naturally occurring lympho- 
matous neoplasm to be effectively controlled by vaccina- 
tion (Churchill et al., 1969). 
Sequence data from this article have been deposited with the EMBL/ 
Gen Bank Data Libraries under Accession No. L22174. 
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Because of similar biological properties, especially its 
lymphotropism, MDV and its antigenically related, apa- 
thogenic vaccine virus, herpesvirus of turkeys (HVT), 
have until recently been classified as gammaherpesvi- 
ruses (Roizman et aL, 1981; Roizman, 1992). In contrast 
to gammaherpesviruses, MDV and HVT have genome 
strL~ctures more closely resembling those of alphaher- 
pesviruses (Cebrian et al., 1982; Fukuchi et al., 1985; 
Igarashi et al., 1987). Consistent with their structural re- 
latedness to alphaherpesviruses, recent data indicate 
that MDV and HVT are phylogenetically more related to 
alphaherpesviruses than gammaherpesviruses (Buck- 
master et al., 1988). This raises interesting questions 
regarding the seeming incongruence between MDV's ge- 
netic and biologic properties. To understand the nature 
of these differences and to identify new gtycoproteins 
potentially important in virus-host cell interactions and 
mechanisms of protective immunity against MD, we have 
become particularly interested in the MDV Us region. 
This stems from the observation that alphaherpesvirus 
Us regions are known to contain a cluster of glycoprotein 
genes and appear to specify determinants for pathogene- 
sis and viral dissemination, rather than those essential 
for virus production (Roizman, 1990a). These determi- 
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nants are encoded by a cluster of "nonessential" or sup- 
plementary essential (Roizman, 1990a) genes which are 
likely to account for many of the unique in vivo properties 
characteristic for a given alphaherpesvirus. The natural 
host-MDV system affords a unique opportunity to exam- 
ine the in vivo role and function of this putative class of 
supplementary essential genes. 
The alphaherpesvirus Us region is flanked by a pair of 
inverted repeat sequences (inverted and terminal repeat 
short, IRs and TRs, respectively, or simply, repeat short, 
Rs). Together, these components make up the S region. 
Alphaherpesvirus Us and other S region genes originate 
from an area specific to members of this group, arguably 
their most divergent coding region. Second they specify 
a cluster of glycoprotein genes important for virus-cell 
interactions and mechanisms of protective immunity. A 
similar cluster in MDV would be particularly significant 
given the paucity of details regarding protective immunity 
against naturally occurring MD tumors. 
The DNA sequence of a 5255-bp segment from Us 
region of the "very virulent" RB1B strain of MDV (wMDV) 
was recently reported (Ross etaL, 1991). This region was 
found to contain open reading frames (ORFs) homolo- 
gous to proteins encoded by HSV US2, US3 (protein ki- 
nase), US6 (glycoprotein D), part of US7 (glycoprotein I), 
and an additional MDV-specific ORF, In this report, we 
extend these results and present a sequence analysis 
of the entire 11.2-kbp MDV Us region ("virulent" GA strain, 
vMDV). 
MATERIALS AND METHODS 
Recombinant plasmids, M13 subcloning, and DNA 
sequencing 
Pathogenic MDV GA strain subclones included EcoRI- 
0, -I, and -V cloned into pBR328 (Gibbs eta/., 1984) 
(pE328-O, pE328-1, and pE328-V, Fig. 1B); BamHI-A and 
8amHI-P1, cloned into pACYC184 and pBR322, respec- 
tively (Fukuchi et aL, 1985) (pBACYC-A and pB322-P1 
(Fig. 1B), kindly provided by Dr. Meihan Nonoyama of the 
Tampa Bay Research Institute, St. Petersburg, FL); and 
GA-02, a phage clone containing a partially digested 
MDV Sau3A insert cloned into the Sa/I site of EMBL3, 
kindly provided by Dr. Paul J. A. Sondermeijer, Intervet 
International, Boxmeer, The Netherlands. The latter clone 
contains most of BamHI-A, all of BamHI-P1, and addi- 
tional 3' flanking sequences, including some of those 
present in pE328-V. This phage clone was used to gener- 
ate the pUC18 subclone, pSP18-A (Fig. 1B). This clone 
contains a 2.5-kb Sail insert with approximately 20 bp of 
EMBL-3's multiple cloning site at its 3' end. Together, 
the above clones (Fig. 1B) were used to generate 
M13mp18 and -19 subclones for use as templates for 
nuoleotide sequencing. 
DNA sequencing of both strands was performed by 
the dideoxy chain-termination method (Sanger et a/., 
1977) using single-stranded M13 templates. Reaction 
products were synthesized and labeled using a 17-mer 
M13 primer, a modified T7 DNA polymerase (Seque- 
nase), [3~S]thio-dATP (NEN), and appropriate deoxy- and 
dideoxynucleotides according to instructions by the man- 
ufacturer (Sequenase sequencing kit; United States Bio- 
chemical Corp., Cleveland, OH) and electrophoresed 
through 7% polyacrylamide/50% urea/Tris-Borate-EDTA 
gels. Remaining sequence gaps were determined by 
substituting M13 primers with synthetic 17-mer oligonu- 
cleotides (under similar reaction conditions, 0.5 pmol/ 
reaction). 
Analysis of sequence data 
Sequences were assembled and analyzed with an IBM 
Personal System 2/Model 50 microcomputer utilizing 
Genepro (Version 4.10; Riverside Scientific Enterprises, 
Seattle, WA) sequence analysis software packages or 
programs obtained from the University of Wisconsin Ge- 
netics Computer Group (UWGCG, Versions 6.2 and 7.0; 
Devereaux etaL, 1984) and run through a VAX 8650 mini- 
computer. Homology searches of the SwissProt (Release 
18.0), GenBank (Release 71.0), and EMBL (Release 30.0) 
databases were performed using the UWGCG programs 
FASTA and TFASTA (Pearson and Lipman, 1988). 
RESULTS 
Defining the MDV Us region and the location of the 
unique-repeat region junctions 
Figure 1 contains a map of the area that was se- 
quenced. This segment is bounded by a pair of Pvull 
sites and spans the 3' half of BamHI-A, extending an 
additional 1.5 kbp to the right of the 3' end of BamHI-P1 
(Figs. 1B and 2). This 11,286-bp segment spans the entire 
Us region, which is 11,160 bp in length and flanked at 
the 5' and 3' ends by a 63-bp stretch of IRs and TRs 
DNA, respectively, each inversely complementary to the 
other (Figs. 1B and 2). Based on Southern blot analysis, 
the IRs-Us junction was previously localized to a 1.4-kb 
Bgll fragment (Fukuchi et al., 1985) located in the second 
of five EcoRI subfragments of BamHI-A (for BamHI-A/ 
EcoRI map, see Wen etaL, 1988). Our sequence analysis 
demonstrates that the IRs-TRs junction is instead located 
in the middle of the third EcoRI subfragment, approxi- 
mately 2-3 kbp downstream from the position reported 
above. This is further supported by Southern blot analysis 
of genomic DNA from the same strain (GA) as above 
(data not shown). Consequently, the Us-TRs junction was 
localized 263 bp downstream of the US8 termination co- 
don (following position 11,223, Fig. 2). 
Nucleotide sequence and identification of open 
reading frames 
The overall guanine plus cytosine ratio of the region 
sequenced was found to be 41%, somewhat below the 
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FIG. 1. Map location of area sequenced and organization of MDV Us ORFs. (A) MDV genome structure and BamHI restriction map outlining area 
sequenced. Restriction enzymes= B, BamHI; E, EcoRI; P, Pstl; and S, Sail. Upper boxes define plasmid clones with BamHI, EcoRI, or Sail-bound 
inserts that were used to generate M 13mpl 8 and -19 templates for sequencing. (B) Organization of M DV Us. ORFs. Lower boxes (with arrows) represent 
location of MDV ORFs. Arrows define direction of transcription/translation. Names of ORFs are displayed above boxes. Basis for nomenclature is 
outlined under Results. 
reported genomic value of 46% (Calnek and Witter, 1991 ). 
Observed frequencies of CpG dinucleotides in the whole 
sequence, or in the coding regions only, did not differ 
significantly from those expected from their mononucleo- 
tide compositions (data not shown). This result agrees 
with those obtained from alphaherpesviruses, while 
sharply contrasting with the CpG deficiencies associated 
with all gammaherpesviruses thus far studied (Efstathiou 
etaL, 1990; Honess etaL, 1989). 
The region sequenced contains at least 11 ORFs likely 
to code for proteins (Fig. 1 B; basis for names is defined 
below). This prediction was primarily based on homology 
and positional organization comparisons to other alpha- 
herpesvirus genes, as well as the observation that alpha- 
herpesviruses generally tend to contain relatively tightly 
packed, unspliced coding regions (Davison and Scott, 
1986; McGeoch et aL, 1985, 1987, 1988; Telford et al., 
1992). Methods for detecting protein coding regions 
based on the use of MDV-derived codon frequency tables 
(using these and previously published MDV sequences; 
Binns and Ross, 1989; Chen et aL, 1992; Jones et al., 
1992; Ross et al., 1989; Scott et al., 1989) or analysis of 
compositional bias (using the UWGCG programs CO- 
DONPREFERENCE and TESTCODE) were inconclusive. 
However, as pointed out previously (Ross et al., 199t), 
MDV-encoded ORFs do exhibit a detectable bias for A- 
T residues in the wobble position. Furthermore, using 
the UWGCG program FRAMES, together with the MDV- 
derived codon frequency table above, the 11 identified 
ORFs clearly show a significantly low pattern of rare 
codon usage not observed following computer-based 
translation of the remaining reading frames (data not 
shown). 
The predicted amino acid sequences of the above 
FIG. 2. Nucleotide and predicted amino acid sequences. The nucleotide sequence is given as the rightward 5' to 3' strand only (numbered 1 to 
11,286). IRs and TRs sequences are located at the 5' and 3' ends, respectively, and are depicted using lowercase symbols; Us sequences are in 
uppercase. Rightward- and leftward-directed predicted amino acid sequences are shown above and below the corresponding nucleotide sequences, 
respectively, in single-letter code. The name of each ORF is given to the left of the first line of its respective sequence. Amino acid sequences are 
numbered from the N terminus, beginning with the first in-frame methionine codon and ending with the amino acid at the C-terminus, which 
precedes the termination codon. Dotted lines identify potential polyadenylation signals. Putative signal peptide and transmembrane domain regions 
of MDV US6 (gD), -US7 (gl), and -US8 (gE) are overlined at the amino and carboxy ends, respectively. Signal peptide overlining continues through 
to the last amino acid to the left of the predicted cleavage site (yon Heijne, 1985). Potential N-glycosylation sites (N-X-S/T) are indicated by dashed 
lines. 





< . . . .  IRs 
I cagctgcgtattttccccgtgcatctcataccgcccatttttgggtagaggtatatttttattAGCCAAATCGTATTCCTGGAAGTITGACAAAACCTGT 100 
89 * G F R I G P L K V F G T 78 
101 CAAACTGACACGGTCCAAGCGAAACTCGAAAAAAAAAGGGGGGGGGGGAGAATATTCTGTAGGACCGGCAGAACTTCTCAAGG•AGAGGAAAGATACACA 200 
78 L S V R D L R F E F F F P P P P S Y E T P G A S $ R L A S $ L Y V 45 
201 TTATTTTTTGTTAGATTTAGGCAAGTTTTGCAGAACCTGCAGGGAATGTATACACCATCAAATCTACTCGACTTATTGCTTGAGTC•AATTTAACAGAAA 300 
44 N N K T L N L C T K C F R C P I Y V G D F R $ S K N S $ D L K V S 12 
301 TTAAAATATATTGATGTTGCGACATATGCATCCTCGCATATGGGGGTGGGACACAGGACGATTATATCCCCAGACATGAA•CTCAAACTGCCATTTTGAT 400 
111 L I Y Q H Q S M H M I 
401 CCCAT•ATTGGAGAGA•AAATTCGCATACATCCTACTTATCGCACACATTGGATGTCGGTCTTTATTCAGGCCATATCAGCTTTCACGGGGGCAAATTCG 500 
I M Q .R Q T G H M E D K K R T G L E S Q G T E N A F S D 27 
501 TATTCATAGATCCGTCATCGATGCAGCGCCAAACCGGACATATGGAAGACAAAAAGAGAACCGGTTTGGAATCGCAGGGGACCGAGAATGCTTTTTCAGA 600 
28 G R D G K D G L L H E G I N E P I L I P $ T I A D L E G I R E L V 60 
601 TGGcAGAGATGGCAAAGATGGATTGTTACATGAAGGAATTAATGAGCCCATTTTGATTCCGTcTACCATCGCAGATCTCGAGGGGATTcGTGAATTGGTc 700 
61R K F R G R L L P F E K C P D F C L R I G G L E A S F H K G Q E E L 94 
701 CGAAAATTCCGTGGTCGTCTACTGCCCTTTGAAAAGTGTCCCGATTTTTGT•TGAGAATTGGGGGTTTGGAGGCCAGCTTTCATAAAGGGCAGGAGGAGC 800 
95 L E Y C E A L Y L P Q P V K M E I V G I V D D V P C L A T G M Q L 127 
801 TGTTAGAGTATTGTGAAGCACTTTATTTACCACAACCTGTTAAGATGGAAATAGTAGGCATTGTAGACGATGTGCCATGTCTGGCAACGGGGATGCAATT 900 
128 L I L V A E G G E V Y A Y E E D T L H K L" A T S F S E F L E I G V 160 
901 ACTCATTCTTGTTGCCGAGGGGGGAGAGGTATATGCCTATGAAGAAGATACTCTGCATAAGTTAGCCACGAGTTTTTCCGAATTCCTTGAAATTGGAGTG 1000 
161K S L G R E V Y H C G E Y I E Q V V H * 179 
1001 AAATCTTTAGGGAGGGAGGTTTACCATTGTGGAGAATATATAGAGCAAGTAGTACATTAGGGGCTGGGTTAAAGACCAAGTAATTTTTGACCGGATATCA 1100 
1101 CGTGATGTAAATTCTAGCAATTATTGTTCCTAGCAGAAGATAAAAGCTGGTAGCTATATAATACAGGCCAAAGTCTCCAAATTACACTTGAGCAGAAAAC 1200 
I M S R D R D R A R P D T R L S S S D N E S D D E D 25 
1201 CTGCTTTCGGCTCCATCGGAGGCAACATGAGTCGTGATCGAGATCGAGCCAGACCCGATACACGATTATCATCGTCAGATAATGAGAGCGACGACGAAGA 1300 
26 Y Q L P H S H P E Y G S D S S D Q D F E L N N V G K F C P L P W K 58 
1301 TTAT•AACTG•CACATTCACATC•GGAATATGGCAGTGACTCGTCCGATCAAGACTTTGAACTTAATAATGTGGGCAAATTTTGTCCTCTACCATGGAAA 1400 
59 P D V A R L C A D T N K L F R C F I R C R L N S G P F H D A L R R A 92 
1401 CCCGATGTCGCTCGGTTATGTGCGGATACAAACAAACTATTTCGATGTTTTATTCGATGTCGACTAAATAGCGGTCCGTTCCACGATGCTCTTCGGAGAG 1500
93 L F D I H M I G R M G Y R L K Q A E W E T I M N L T P R Q S L H L 125 
1501 CACTATTCGATATTCATATGATTGGTCGAATGGGATATCGACTAAAACAAGCCGAATGGGAAACTATCATGAATTTGACCCCACGCCAAAGTCTACATCT 1600 
126 R R T L R D A D S R S A H P I S D I Y A S D S I F H P I A A S $ G 158 
1601 GCGCAGGACTCTGAGGGATGCTGATAGTCGAAGCGCCCAl•CCTATATCCGATATATATGCCTCCGATAGCATTTTTCACCCAATCGCTGCGTCCTCGGGA 1700 
159 T I S S D C D V K G M N D L S V D S K L H * 179 
1701 ACTATTTCTTCAGACTGCGATGTAAAAGGAATGAACGATTTGTCGGTAGACAGTAAATTGCATTAACTAT•CAGACTTGAAGAGAAAGCTCTTATTATAT 1800 
1801 AATTTTAATTGTTAGACATAGAGCCGACATTCTTTGATCTATCTAATGAGATAAAATAATAGATTTTGGATTTATTTGTCATGATCTGTTGCAACAAA•G 1900 
1901 CTGACCCCCCCCATCCATGAAGGGGCGTGT•AAATAACGTGTTGCCTTTTTGTTGTATATGAAGATATTTAATGTGGCGTTGAGCCTAATGAGAGGAGAA 2000 
I M A M W S L R R K S S R S V Q 15 
2001 CGTGTTTGAATACTGGAGACGAGCGCCGTGTAAGATTAAAACATATTGGAGAGGTATGGCCATGTGGTCTCTACGGCGCAAATCTAGCAGGAGTGTGCAA 2100 
16 L R V D S P K E Q S Y D I L S A G" G E H V A L L P K S V R S L A R T 49 
2101 •TCCGGGTAGATTCTCCAAAAGAACAGAGTTATGATATACTTTCTGCCGGCGGGGAACATGTTGCGCTATTGCCTAAATCTGTACGCAGTCTAGCCAGGA 2200 
50 I L T A A T I S Q A A M K A G K P P S S R L W G E I F D R M T V T 82 
2201 CCATATTAACCGCCGCTACGATCTCCCAGGCTGCTATGAAAGCTGGAAAACCACCATCGTCTCGTTTGTGGGGTGAGATATTCGACAGAATGACTGTCAC 2300 
83 L N E Y D I S A S P F H P T D P T R K I V G R A L R C I E R A P L 115 
2301 GCTTAACGAATATGATATTTCTGCTTCGCCATTCCACCCGACAGACCCGACGAGAAAAATTGTAGGCCGGGCTTTACGGTGTATTGAACGTGCTCCTCTT 2400
116 T H E E M D T R F T I M M Y W C C L G H A G Y C T V S R L Y E K N V 149 
2401 ACACACGAAGAAATGGACACTCGGTTTACTATCATGATGTATTGGTGTTGTCTTGGACATGCTGGATACTGTACTGTTTCGCGCTTATATGAGAAGAATG 2500
150 R L M D I V G S A T G C G I S P L P E I E S Y W K P L C R A V A T 182 
2501 TCCGTCTTATGGA•ATAGTAGGTTCGGCAA•GGGCTGTGGAATAAGTCCACTCCCCGAAATAGAGTCTTATTGGAAACCTTTATGTCGTGCCGTCGCTAC 2600 
183 K G N A A I G D D A E L A H Y L T N L R E S P T G D G E S Y L * 213 
2601 TAA•GGGAATGCAG•AAT•GGTGATGATGCTGAATTGGCACATTATCTGACAAATCTTCGGGAATCG•CAACAGGAGACGGGGAATCCTACTTATAACTA 2700 
2701 ATCGCA~AATTATTAATAGGATTTTAGGAAAAACTGCTACTAACGTTGTTTAAATAATAAAATTTTATTTTCAATAAGGcATTA~AGTGTTGTCATGATT 2800 
2801 GTATGTATTATATGGGGTATGCATGAGGATTACTTCGATTGAAACTTTGTCTAAATGTCTGTAGGATTTTACTATTCATTAGTCTGGATCGAGGCGGACG 2900 
351 * I P Y A H P N S R N F S Q R F T Q L I K S N M L R S R P P R 322 
2901 TAAATGGAGATTGCGGCAAATGTAGGGGTGCTGGTACATAAGACCTCCAACATCCATTCGACTCATCGGCCTGCGTCCAAATGGATATGTTGATGTACCT 3000 
321 L H L N R C I Y P H Q Y M L G G V D M R S M P R R G F P Y T S T G 289 
3001 TGTAAAGTTATGACATTAGAAGATCGATGGTGAATAGTGGGATCTATATCCATGCTATTCTCAATATTGCATGATATGCAATGTTCCCGGTTAGGTTTGA 3100 
288 Q L T I V N S S R H H I T P D I D M S N E I N C S I C H E R N P K 256 
3101 TAAGATCATGTATGGTTCTATAATACAACTCCTCTTCAGAAGAATCATTTATTTTATGTCCACTGTCCTTGGATATTCCAGTTTCTGTCAATCGATTCGC 3200 
255 I L D H I T R Y Y L E E E S S D N I K H G S D K S I G T E T L R N A 222 
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3201 TTGCATTTGCGTGCAGCATGTCTTGATGGCATTTCCTATGCTATCATCCGGCAGGCCTAAGGGTGTTCTATACTCGCACACAGGTAGAGCAAGAACCA•G 3300 
221 Q M Q T C C T K I A N G I S D D P L G L P T R Y E C V P L A L V V 189 
3301 GCATATCGAGCTAC•T•TATTGCCC•GCTAAGGACATTTCTTG•AGA•TGTATTGT•ATGAACATATTTCGTGTATTGTGTCGATCATAACCCTTGTTGA 3400 
188 A Y R A V E I A G S L V N R A S Q I T M F M N R T N H R D Y G K N 156 
3401 TT•CTATGGAAAGCATTGTGGTCCAGTTTTCCAGATGAAATGAAAA•AATGCGGG•AAAAATGGT•CCACCTGTTTCATCTTCAATGCATCTCTCACAT• 3500 
155 I G I S L M T T W N E L H F S F L A P L F P G V Q K M K L A D R V D 122 
3501 C•AAGTT•TATAGAATATTCT•CACTGACCAGTTTCGGTAAGATCAGTTTCTGTAAAATTTGTGATAGTTTCAATCGAAAACATTTTGTCCATCATGGCA 3600 
121 W T R Y F I R W Q G T E T L D T E T F N T I T E I S F M K D M M A 89 
3601 AAAAATCTATAGGCAGA•CAGATAAC•ATTTGACACCACATATC•TTGTGTATATCAAACGATGTAATAGATCCCTCGTTAGTAGATATGGTACATAAAA 3700 
88 F F R Y A S W I V M Q C W M D K H I D F S T I S G E N T S I T C L 56 
3701 GGCCTAATCTCT•TCGGGCTTCCATA•ATTGAACGATT•CTTCTGTGAATTCATCAACAA•CACATGCCAAAAATTTACATTAGTAATCTTTCTCGGTGG 3800 
55 L G L R E R A E M C Q V I G E T F E D V V V H W F N V N T I K R P P 22 
3801 •TTACCAAATCGT•CT•TTGGTATATCCATATCATCGAACATTGTAGCATTGACT•TGCTCATCGTTGTCTTTCAAATGCGCTCGATTGTTGAATCTCTC 3900 
21 K G F R G R P I D M D D F M T A N V R S M I 
3901 CTGATGTTAGAAGTATATGGAAGATAGCCTGGATACATAAGTGATCTAGAAGGGTTTGTTATTGCACTAATATACAAATTATACGTGACACTATAGCGAC 4000
4001 GGTTGTAGCGATGCAC•TAATCGTAATGTGTATACGCCC•ATCATGTAATTATATCTAATTGGTAGCAAGTAGGTCTGT•GAATAACAGCTAATGA•TAC 4100 
270 * H S 269 
4101 CGGCTCTACATTTTTTCTGTAT TCGTGACTTTCCTGTCGCAGTGTAACGAACCGGAATTGCAATCGCATCTCTATCTTCTTTCTTGCAACATTTTCCACA 4200 
268 G A R C K K Q I R S K G T A T Y R V P I A I A D R D E K K C C K G C 235 
4201 ACAGAATAATCTGCCGGGTGTACTACTCATTTGAGGTGGTTCGATT TCCGGAGGTTTTAGAGGATTGGGTGGGGACCCGAGGATTTTGTATACACATACC 4300 
234 C F L R G P T S S M Q P P E ! E P P K L P N P P $ G L I K Y V C V 202 
4301 ATATCACTGTCGCAAAAATGCGCTCTATCTTCTGGGGTGTCGAACTTCGGTTCCCATGTAGATGTCAAGAGAGTTT GAATATTGTCGGGAATGGCCCACG 4400 
201 M D S D C F H A R D E P T D F K P E W T S T L L T Q ! N D P I A W 169 
4401 GCATACCGGACCAGGTCCCAGACACTTTGATTGCAAGTAACCTTTTTGGCAAAGGAATACATTCGAGCGCAAT GC CATATATCTGCCGCCCCAACTAT 4500 
168 P M G S W T G S V K I A L L R K P L P I C E L A ! A C I D A A G V ! 135 
4501 CCACAAGCTATGTGGAGCATTACCAGAAACTTCAGATTCCAACATCAAATATCCAGATAGAACATCCTGCCATT CTGTGGAACATCCTGCAACATCTTCA 4600 
134 W L S H P A N G S V E S E L M L Y G S L V D Q W E T S C G A V D E 102 
4601 AATAGCCGCACTATAAACGAATCCCTAGTT CCGGCCAATCCGGTACCACGAACTCCAGTTCCATCTGGTGGCTTTGTCCTTACTATCGGTCGATGTTGCC 4700 
101 F L R V I F S D R T G A L G T G R V G T G D P P K T R V I P R H Q 69 
4701 GAGGAAGAATTAACATGGGTTTGGCAAAACGGAATAGGTCTGCAGCTCTGGCGAT TATGGGCACACCCACATCATCCTGTAT TTGTTCCATACAT TGCTT 4800 
68 R P L I L M P K A F R F L D A A R A I I P V G V D D Q I Q E M C Q K 35 
4801 TATAAGGAATATCCATAAAGTAGATGCAGCATCTCTAGATCT TCCTGGCAATCGAT CGCATTCAT CTAGAAGT GTGACTATAGTTATCATGGACACACCC 4900 
34 I L F I W L T S A A D R S R G P L R D C E D L L T V I T I M S V G 2 
4901 ATCTTCACCI'CCACCAATAATCTTT TT TATT GTTAATAACTGGGCCGGTCTGATCT CCAAATCT TATACTCTGGTAGAATATGAAACAGGGTTAAAACTA 5000 
US2 1 M 
US3 I M S S T P E A E T M E C G I S S S K V H D S K T N T T Y G 29 
(PK) 5001 GGTAATAGACTGGATGTCTTCGACTCCGGAGGCAGAAACGATGGAATGTGGCATTTCTTCGTCGAAAGTACACGACTCTAAAACTAATACTACCTACGGA 5100 
30 I I H N S I N G T D T T L F D T F P D S T D N A E V T G D V 0 D V K 63 
5101 ATTATACATAACAGCATCAATGGTACGGATACGACGTTGT TTGATACTTTTCCCGACAGTACCGATAACGCGGAAGTGACGGGGGATGTGGACGATGT GA 5200 
64 T E S S P E S Q S E D L S P F G ~N D G N E S P E T V T D I D A V S 96 
5201 AGACTGAGAGCTCTCCCGAGTCCCAATCTGAAGAT TTGTCACCTTTTGGGAACGATGGAAATGAATCCCCCGAAACGGTGACGGACATTGATGCAGTTTC 5300 
97 A V R M Q Y N I V S S L P P G S E G Y I Y V C T K R G D N T K R K 129 
5301 AGCTGTGCGAATGCAGTATAACATTGTTTCATCGTTACCGCCCGGATCTGAAGGGTATATCTATGT T ACAAAGCGTGGGGATAATACCAAGAGAAAA 5400 
130 V I V K A V T G G K T L G S E I D I L K K M S H R S I I R L V H A Y 163 
5401 GTCATT GTGAAAGCT GTGACTGGT GGCAAAACCCTTGGGAGTGAAATT GATATATTAAAAAAAATGTCTCACCGCT CCATAATTAGATTAGTTCATGCTT 5500 
164 R W K S T V C M V M P K Y K C D L F T Y I D I M G P L P L N Q I I 196 
5501 ATAGATGGAAATCGACAGTTTGTATGGTAATGCCTAAATACAAATGCGACTTGTTTACGTACATAGATATCATGGGACCATTGCCACTAAATCAAATAAT 5600 
197 T I E R G L L G A L A Y I H E K G I I H R D V K T E N I F L D K P 229 
5601 TACGATAGAACGGGGTTTGCTTGGAGCAT TGGCATATATCCACGAAAAGGGTATAATACATCGTGATGTAAAAACTGAAAATATATTT T TGGATAAACCT 5700 
230 E N V V L G D F G A A C K L D E H T D K P K C Y G W S G T L E T N S 263 
5701 GAAAATGTAGTATTGGGGGACTTTGGGGCAGCATGTAAATTAGATGAACATACAGATAAACCCAAATGTTAT GATGGAGT GGAACTCTGGAAACCAATT 5800 
264 P E L L A L D P Y C T K T D I W S A G L V L F E M S V K N I T F F 296 
5801 CG•CTGAACTGCTTGCACTTGATCCATACTGTACAAAAACTGATATATGGAGTGCAGGATTAGTTCTGTTTGAGATGTCAGTAAAAAATATAACCTTTTT 5900 
297 G K Q V N G S G S Q L R S I I R C L Q V H P L E F P Q N N S T N L 329 
5901 TGGCAAACAAGTAAACGGCTCAGGTTCT AGCTGAGAT CCATAATTAGATGCCTGCAAGTCCATCCGT TGGAATTTCCACAGAACAATTCTACAAACTTA 6000 
330 C K H F K Q Y A I Q L R H P Y A I P Q I I R K S G M T M D L E Y A I 363 
6001 TGCAAACACTTCAAGCAGTACGCGAT TCAGTTACGACATCCATATGCAATCCCTCAGATTATACGAAAGAGTGGTATGACGATGGATCTTGAATATGCTA 6100 
364" A K M L T F D Q E F R P S A Q D I L M L P L F T K E P A D A L Y T 396 
6101 TTGCAAAAATGCTCACATTCGATCAGGAGT T AGACCATCT GCCCAAGATATTT TAAT GTTGCCTCT T TTTACTAAAGAACCCGCTGACGCATTATACAC 6200 
397 I T A A H M * 402 
6201 GATAACTGCCGCTCATATGTAAACACCCGT CAAAAATAACTTCAATGATTCATT TATAATATATACTACGCGTTACCTGCAATAATGACAACATTCGAA 6300 
FiG. 2--Condnued 
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SORF4 I M A P S G P T P Y S H R P Q I K H Y G T F S 0 23 
6301 GT•TTTGAAGATTCGCAGACCTTTTTTGCGAATGG•ACCTTCGGGACCTACG•CATATTCCCA•AGACCGCAAATAAAGCATTATGGAACATTTTCGGAT 6400 
24 C M R Y T L N D E S K V D D R C S D I H N S L A Q S N V T S S M S V 57 
6401 TGCAT GAGATATACT CTAAACGATGAGAGTAAGGTAGATGATAGATGT  CAGACATACATAACTCCTTAGCACAAT CCAAT GT TACTTCAAGCATGTCTG 6500 
58 M N D $ E E C P L I N G P S M Q A E D P K S V F Y K V R K P 0 R S 90 
6501 TAATGAACGATTCGGAAGAATGT CCATTAATAAATGGACCT TCGATGCAGGCAGAGGACCCTAAAAGTGT  T TT TATAAAG TTCGTAAGCCTGACCGAAG 6600 
91 R D F S W Q N L N S H G N S G L R R E K Y I R S S K R R W K N P E 123 
6601 TCGTGATTTTT•ATGGCAAAATCTGAACTCCCATGGCAATAGTGGTCTACGTCGTGAAAAATATATA•GTTC•TCTAAGAGGCGATGGAAGAATCCCGAG 6700 
124 I F K V S L K C E $ I G A G N G I K I S F £ F F * 147 
6701 ATATTTAAGGTATCTTTGAAATGTGAATCAATTGGCGCTGGTAACGGAATAAAAATTT•ATT•T•ATTTTTCTAACATTATAATATATCAGATC•TTT•T 6800
6801 TATAIACTTATTTTCAT~GTCGGGATATGACTAACGTATACTAA~TTACAAGAAACAACT~CTTAACGTCGAACATAACGGAAATAAAAATATATATAGC 6900 
US6 I M N R Y R Y E S "I ~"' F R Y I S S T R M I 20 
(gD) 6901 GTCTCCTATAACT•TTATATTGGCA•CTTTTAGAGCTTCGGTATGAATAGATACAGATATGAAAGTATTTTTTTTAGATATATCTCATCCACGA•AATGA 7000 
21 L"'" I I C L L L G I G P M S A M G L K K P N S P I I P T L H P K G N 53 
7001 TT•T•ATAATC•GTTTACTTTTGGGAA•TGGGGA•ATGTCCGCAATGGGACTTAAGAAAGACAATTCTCCGATCATTccCA•ATTACATCCGAAAGGTAA 7100 
54 E N L R A T L N E Y K I P S P L F D T L D N $ Y E T K H V I Y T D 86 
7101 TGAAAACCTCCGGG•TACTCT•AATGAATACAAAATCCCGTCTCCACTGTTTGATACACTTGACAATTCATATGAGACAAAACA•GTAATATATACGGAT 7200 
87 ~-C-  ~ F A V L N P F G D P K Y T L L S L L L M G R R K Y D A L V A W 120 
7201 AATTGTAGTTTTGCTGTTTTGAATCCATTTGG•GAT•CGAAATATACGCTTCTCAGTTTACTGTTGATGGGACGACGCAAATATGATGCTCTAGTAGCAT ~00 
121 F V L G R A C G R P I Y L R E Y A ~ - C - ~ T N E P F G T C K L K S L  153 
7301 GGTTTGTCTTGGGCAGAGCATGTGGGAGACCAATTTATTTACGTGAATATGCCAACTG•TCTACTAATGAACCATTTGGAACTTGTAAATTAAAGTCCCT 7400 
154 G W W D R R Y A M T S Y I D R D E L K L I I A A P S R E L S G L Y 186 
7401 AGGATGGTGGGATAGAAGATATG•AATGACGAGTTATATCGATCGAGATGAATTGAAATTGATTATTGCAGCACCCAGTCGTGAGCTAAGTGGATTATAT 7500 
187 T R L I I I N G E P I S S 0 I L L T V K G T C S F S R R G I K 0 N K 220 
7501 ACGCGTTTAATAATTATTAATGGAGAACCCATTTCGAGTGACATATTACTGACTGTTAAAGGAACATGTAGTTTTTCGAGACGGGGGATAAAGGATAACA 7600 
221 L C K P F S F F V ~-G-  T T R L L D M V R T G T P R A H E E N V K Q 253 
7601 AACTATGCAAA•CGTTCAGTTTTTTTGTCAATGGTACAACACGGCTGTTAGACATGGTG•GAACAGGAACCCCGAGAGCCCATGAAGAAAATGTGAAGCA 7700 
254 W L E R N G G K H L P I V V E T S M Q Q V S N L P R S F R D S Y L 286 
7701 GTGGCTTGAACGAAATGGTGGTAAACATCTACCAATCGTCGTCGAAACATCTATGCAACAAGTCTCAAATTTGC•GAGAAGTTTTAGAGATTCATATTTA 7800 
287 K S P D D D K Y N D V K M T S A T T N ~ - I -  T T S V D G Y T G L T N R 320 
7801 AAATCAC•TGACGACGATAAATATAATGACGTCAAAATGACATCGGCCACTACTAATAACATTACCACCTCCGTGGATGGTTACACTGGACTCACTAAT• 7900 
321 P E D F E K A P Y I T K R P I I S V E E A S S Q S P K I S T E K K 353 
7901 GG•C•GAGGACTTTGAGAAAGCACCATACATAACTAAACGACCGATAATCTCTGTCGAGGAGGCATCCAGTCAATCACCTAAAATATCAACAGAAAAAAA 8000 
354 S R T Q I I I S L' V V L C V 'M F C F I V I G S G I W I L R K H R' K 386 
8001 ATCCCGAACGCAAATAATAATTTCA•TAGTTGTTCTATGCGTCATGTTTTGTTTCATTGTAATCGGGTCTGGTATATGGATCCTTCGCAAACACCGCAAA 8100 
387 T V M Y D R R R P S R R A Y S R L * 403 
8101 ACGGTGATGTATGATAGACGTCGTCCATCAAGACGGGCATATT•CCGCCTATAACACGTGTTTGGTATGGGCGTGTCGCTATAGTGCATAAGAAGTTGAC 8200 
US7 I M Y V L Q L L F ' W I R L F R  14 
(gl) 8201 TACATTGATCAATGACATTATATAGCTTCTTTGGTCAGATAGACGGCGTGTGTGATTGCGATGTATGTACTACAATTATTATTTTGGATCCGCCTCTTTC 8300 
15 G I W S I V Y T G T S V T L S T 0 Q £ A L V A F R G L D K M V N V 47 
8301 GAGGCATC•GGTCTATAGTTTATACTGGAACATCTGTTACGTTATCAACGGACCAATCT•CTCTTGTTGCGTTCCGCGGATTAGATAAAATGGTGAATGT 8400 
48 R G Q L L F L G D Q T R T S S Y T G T T E I L K W D E E Y K C Y S 80 
8401 ACGCGGCCAACTTTTATTCCTGGGCGACCAGACTCGGACCAGTTCTTATACAGGAACGACGGAAATCTTGAAATGGGATGAAGAATATAAATGCTATTCC 8500 
81V L H A T S Y M D C P A I D A T V F R G C R D A V V Y A Q P H G R V 114 
8501 GTTCTACATGCGACATCATATATGGATTGTCCTGCTATAGACGC•ACGGTATTCAGAGGCTGTAGAGACGCTGTGGTATATGCTCAACCTCATGGTAGAG 8600 
115 Q P F P E K G T L L R I V E P R V S D T G S Y Y I R V S L A- G R N 147 
8601 TA•AACCTTT•C•CGAAAAGGGAACATTGTTGAGAATTGT•GAACC•AGAGTATCAGATACAGGCAGCTATTACATACGTGTATCTCTCG•TGGAAGAAA 8700 
148 M S D I F R M V V I I R S S K S W A C N H S A S S F Q A H K C I R 180 
8701 TATGAGCGATATATTTAGAATGGTTGTTATTATAAGGAGTAGCAAATCTTGGGCCTGTAATCA•TCTGCTAGTTCATTTCAGGC•CATAAATGTATTCGC 8800 
181Y V D R M A F E N Y L I G H V G N L L D S D S E L H A I Y ~- I -  T P 0 214 
8801 TATGTCGACCGTATGGCCTTTGAAAATTAT•TGATTGGACATGTAGGCAATTTGCTGGACAGTGACTCGGAATTGCATGCAATTTATAATATTACTCCCC 8900 
215 S I S T D I N I V T T P F Y D N S G T I Y S P T V F N L F N ~-N-  ~ 247 
8901 AAT•CATTTCCACA•ATATTAATATTGTAACGA•TCCATTTTACGATAATT•GGGAACAATTTATTCACCTACGGTTTTTAATTTGTTTAATAACAATTC 9000
248 H V D A M ~-S-  T G M W N T V L K Y T L P R L I Y F S T M I V L C I 280 
9001 CCATGTCGATGCAATGAATTCGACTGGTATGTGGAATAC•GTTTTAAAATATAC•CTTC•AAGGCTTATTTACTTTTCTACGATGATTGTACTATGTATA 9100 
2811 A L A I Y L V C E R C R S P H R R I Y I G E P R S D E A P L I T S 314 
9101 ATAGCATTGGCAATTTATTTGGTCTGTGAAAGGTGCCGCTCTCCCCATCGTAGGATATACATCGGTGAACCAAGATCTGATGAGGCCCCACTCATCACTT 9200 
315 A V N E S F Q Y 0 Y N V K E T P S 0 V I E K E L M E K L K K K V E 347 
9201 CTGCAGTTAACGAATCATTTCAATATGATTATAATGTAAAGGAAACTCCTTCAGATGTTATTGAAAAGGAGTTGATGGAAAAACTGAAGAAGAAAGTCGA 9300 
FIG. 2 - -  Continued 
330 BRUNOVSKIS AND VELICER 
348 L L E R E E C V * 355 
9301 ATTGTTGGAAAGAGAAGAATGTGTATAGGT T GAGAAACTAT TATAGGTAGGTGGTACCT GTTAGCTTAGTATAAGGGGAGGAGCCGTTTCTTGTTTTAA 9400 
US8 I M 'C V F Q I L I I V T T 12 
(gE) 9401 AGACACGAACA•AAGGCCGTAAGTTTTATATGTGAATTTTGTGCATGTCTGCGAGTCAGCGTCATAATGTGTGTTTTCCAAATCCTGATAATAGTGACGA 9500 
13 I K V A G T A N I N H I D V P A G H S A T T T I P R Y P P V V D G 45 
9501 CGATCAAAGTAGCTGGAACGGCCAACATAAATCATATAGACGTT CC GCAGGACATTCT GCTACAACGACGATCCCGCGATATCCACCAGTTGTCGATGG 9600 
46 T L Y T E T W T W I P N H C ~ -E- T A T G Y V C L E S A H C F T D L 78 
9601 GACCCTTTACACCGAGACGTGGACATGGATTCCCAATCACTGCAACGAAACGGCAACAGGCTATGTATGT CTG AAAGTGCTCACTGTTTTACCGATTTG 9700 
79 I L G V S C M R Y A D E I V L R T D K F I V D A G S I K Q I E $ L S 112 
9701 ATATTAGGAGTATCCTGCATGAGGTATGCGGATGAAATCGTCTTACGAACTGATAAATTTATTGTCGATGCGGGATCCATTAAACAAATAGAATCGCTAA 9800
113 L N G V P N I F L $ T K A £ N K L E I L I~ -A-  ~J L Q N A G I Y I R Y 145 
9801 GTcTGAATGGAGTTCCGAATATATT•CTAT•TACGAAAGCAAGTAACAAGTTGGAGATACTAAATGCTAGCCTA•AAAATGCGGGTATCTA•ATTCGGTA 9900 
146 S R N G T R T A K L D V V V V G V L G Q A R D R l P Q M S S P M I 178 
9901 TT•TAGAAA•GGGA••AGGA•T••AAAGcTGGATGTT•TTGT••TTGG••TTTTGGGT•AA••AA••GAT•G•CTA•••cAAAT•T•CAGTc•TATGAT• 10000 
179 S S H A D I K L S L K N F K A L V Y H V G D T I ~-V-~ T A V I L G P 212 
10001 TcATccCAcGCCGATATCAAGTTGTCATTAAAAAACTTTAAAGcATTAGTATATCACGTGGGAGATAcTATCAATGTCTCGACGGCGGTTATAcTAGGAc 10100 
213 S P E I F T L E F R V L F L R Y ~-P -T  C K F V T I Y E P C I F H P 245 
10101 cTTCTccGGAGATATTCAcATTGGAATTTAG•GTGTTGTTCCTCcGTTATAATcCAACGTGCAAGTTCGTCACGATTTATGAAccTTGTATATTTcACCC 10200 
246 K E P E C I T T A E Q S V C H F A S N I D I L Q I A A A R $ E ~-C-  278 
10201 CAAAGAA~CAGAGTGTATTACTACTGCAGAACAATCGGTATGTCATTTCG~ATC~AACATTGACATTCTGCAGATAGCCGCCG~ACGTTCTGAAAATTGT 10300 
279 S T G Y R R C I Y D T A I D E $ V Q A R L T F I E P G I P $ F K M K 312 
10301 AGCACAGGGTATCGTAGATGTATTTATGACACGGCTATCGATGAATCTGTGCAGGCCAGATTAACATTCATAGAACCAGGAATTCCTTCCTTTAAAATGA 10400 
313 D V Q V D D A G L Y V V V A L Y N G R P S A W T Y I Y L S T V E T 345 
10401 AAGATGTCCAGGTAGACGATGCTGGATTGTATGTGGTTGTGGCTTTATACAATGGACGTCCAAGTGCATGGACTTACATTTATTTGTCAACGGTGGAAAC 10500 
346 Y L N V Y E N Y H K P G F G Y K S F L Q ~-S -  ~ I V D E N E A S D W 378 
10501 ATATCTTAATGTATATGAAAACTA•CACAAGCCGGGATTTGGGTATAAATCATTTCTACAGAACAGTA•TATCGTCGACGAAAATGAGGCTAGCGATTGG 10600 
379 S S S S I K R R N ~-G-  T I I Y D I L L T S L S I G A I I I V I V G G 412 
10601 TCCAGCTCGTCCATTAAACGGAGAAATAATGGTACTATCATTTATGATATTTTA•TCACATCGCTATCAATTGGGGCGATTATTATCGTCATAGTAGGGG 10700 
413 V C I A I L I R R R R R R R T R G L F D E Y P K Y M T L P G N D L 445 
10701 GTGTTTGTATTGCCATATTAATTAGGCGTAGGAGACGACGT•GCACGAGGGGGTTATTCGATGAATATCCCAAATATATGACGCTACCAGGAAACGATCT 10800 
446 G G M N V P Y D N T C S G N Q V E Y Y Q E K S A K M K R M G S G Y 478 
10801 GGGGGGCATGAATGTAC•GTATGATAATACATGCTCTGGTAACCAAGTTGAATATTATCAAGAAAAGTCGGCTAAAATGAAAAGAATGGGTTCGGGTTAT 10900 
479 T A W L K N D M P K I R K R L D L Y H * 497 
10901 ACCG•TTGGCTAAAAAATGATATGCCGAAAATTAGGAAACGCTTAGATTTATACCACTGATATGTACATATTTAAACTTAATGGGATATAGTATATGGAC 11000 
11001 GTCTATATGACGAGAGTAAATAAA~TGA~AATG~AAATGAAG~TGATCTATATTGTGCTTTATATTGGGACAAACCACT~GCACAAG~TCATTCAACACA 11100 
11101 TCCACTCTTGGACAGCTTCATGTTAAAATAAACTGTAAATCATTCAATGATAATGGGAGAAGAATGTGAGCAAGGATCCATGGTGTCTGCTTTTTATAGA 11200 
11201 TACTACCGCAATGCTA•ATATAAaataaaaatatacctctacccaaaaatgggcggtatgagatgcacggggaaaatacgcagctg 11286 
TRs . . . .  > 
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ORFs (beginning from the first ATG codon) are shown 
relative to the nucieotide sequence in Fig. 2. Since their 
gene products are yet to be characterized, in order to 
simplify identification, 7 have been named (Fig. 1 B, Table 
1) based on homology (see below) to HSV-l-encoded Us 
QRFs (McGeoch et aL, 1985). When appropriate, the let- 
ters MDV will preface the homolog's name to indicate 
the ORF's origin. The four nonalphaherpesvirus-related 
ORFs have been arbitrarily named SORFs 1, -2, -3 and 
-4 (unique Short region Open Reading Frame). Due to 
the A-T-rich nature of MDV, there are numerous TATA- 
like sequences for transcriptional initiation, more than 
are likely to have functional relevance. Therefore, these 
sites have not been highlighted in Fig. 2. All of the ORFs 
contain potential AUG (ATG) codons in a favorable con- 
text for translational initiation (purine in -3  position and/ 
or guanine in +4 position; Kozak, 1989). Such a context 
is lacking for the first methionine codons of SORF2 and 
US3 (PK), but is observed among secondary methionine 
codons which correspond to amino acid positions 8 and 
10, respectively (Fig. 2). Potential polyadenylation sig- 
nals, according to HSV-1 usage patterns (McGeoch, 
1991), are identified in Fig. 2; ORF locations, lengths (AA), 
and predicted molecular masses of the putative transla- 
tional products are outlined in Table 1. 
Database- and computer-assisted homology 
comparisons 
Using the computer program FASTA or TFASTA (Pear- 
son and Lipman, 1988), each of the 11 predicted amino 
acid sequences was screened against the SwissProt 
protein database or GenBank/EMBL nucleic acid data- 
bases, respectively, in addition to recently published 
pseudorabies virus (PRV) (van Zijl et aL, 1990) and equine 
herpesvirus-1 (EHV-1) (Colle eta/., 1992; Elton eta/., 1991; 
Holden et al., 1992a,b; Telford et aL, 1992) S segment 
gene sequences not present in these databases. Opti- 
mized FASTA/TFASTA scores greater than 100 were ini- 
tially considered as potential candidates possessing a 
DNA SEQUENCE OF THE MDV Us REGION 
TABLE 1 
Summary of MDV Us ORF Data 
331 
ORF FASTA scores with 
ORF stop 
Name start Oodons Mr 8 HSV-1 VZ PRV EHV-1 Properties/references 
SORF1 331 62 89 10 .1  . . . .  
SORF2 521 1060 179 20 .1  . . . .  
US1 1227 1766 179 20.4 101 160 218 209 
US10 2056 2697 213 23.6 134 147 - -  260 
SORF3 3863 2805 351 40.6 . . . .  
US2 4902 4090 270 29.7 335 - -  168 355 
US3 5014 6222 402 44.7 611 616 563 551 
SORF4 6332 6775 147 16.8 . . . .  
US6 6943 8154 403 42.6 ° 211 - -  279 246 
US7 8261 9328 355 38.39 145 228 188 242 
US8 9467 10960 497 53.79 192 376 217 402 
Homologous to FPV ORF4 ° 
Regulatory protein d 
Virion protein e 
Protein kinase 
Membrane glycoprotein D (gD) g 
Membrane glycoprotein I (gl) 9 
Membrane glycoprotein E (gE) 9 
Predicted, in absence of posttranslational modifications. 
b Based on sequences that follow the predicted signal peptide cleavage site. 
° FASTA = 237; Tomley et al. (1988). 
~ Holden et al, (1992a); Jackers et al. (1992); Sears et aL (1985). 
e Holden et al. (1992b); McGeoch et al. (1988). 
rLeader and Purves (1988); Purves et al. (1991); Zhang and Leader (1990). 
gOampadelli-Fiume et al, (1990); Johnson and Spear (1989); Long et al. (1992); Peeters et al. (1993). 
h Dubin et al. (1991); Johnson et al, (1988); Whealy et al. (1993); Zsak et al. (1992). 
significant degree of amino acid similarity. The results 
of this analysis are in Table 1; the scores obtained are 
comparable to those of previously established S region 
homologies. Further evidence for homology was derived 
from dot matrix analyses and % similarity/identity analy- 
sis (using GAP; data not shown). Homologies between 
MDVs and their alphaherpesvirus S region counterparts 
ranged between 40 and 60% similarity and between 20 
and 40% identity (data not shown). Apart from MDV US3, 
60RFs (MDV US1, -10,-2,-6,-7 and -8) were found to be 
exclusively homologous to alphaherpesvirus S segment 
genes; in contrast, SORF1,-3, and -4 failed to show statis- 
tically significant homology with any sequences in either 
of the two databases. On the other hand, using SORF2 
as a probe for FASTA analysis, a FASTA score of 237 
was obtained, indicating homology to an uncharacterized 
f0wlpox virus (FPV) ORF (e.g., FPV ORF4; Tomley et al., 
1988). Upon alignment, these sequences were found to 
exhibit 67% similarity and 42% identity over the 100 AA 
aligned (Fig. 3). Like other US3 homologs, MDV's counter- 
part exhibits homology to the serine-threonine protein 
kinase superfamily (Hanks eta/., 1988), as evidenced by 
a relatively large number of FASTA scores between 150 
and 250. Nevertheless, these scores were three- to four- 
fold lower than those obtained between US3 homologs 
of HSV, VZV, and PRV (Table 1). The US3 gene family of 
herpesvirus protein kinases appear to define a distinct 
subfamily within the serine-threonine protein kinase su- 
perfamily; it is thought that related cellular counterparts 
exist and await future characterization (Hanks et aL, 
1988). Homologies to HSV-2 US2, -3, -6, and -7 are not 
presented in this report, inasmuch as their ORFs exhibit 
greater than 70% identity to their HSV-1 counterparts 
(McGeoch et a/., 1987) and result in homologies with 
MDV that basically resemble those with HSV-1. MDV US6 
exhibits demonstrable homology to HSV-2 US4 (FASTA 
= 100) and its PRV counterpart, gX (FASTA = 90). This 
is consistent with earlier findings suggesting duplication 
and divergence of S component glycoprotein genes from 
common precursors (McGeoch, 1990). 
Analysis of MDV glycoproteins, gD, gl, and gE 
In comparing the gB homologs of seven different her- 
pesviruses included in the alpha ~, beta-, and gammaher- 
pesvirus subfamilies, there is complete conservation of 
10 cysteine residues (Ross et al., 1989). Alphaherpesvi- 
rus S component glycoproteins have also been found to 
contain similar patterns of conserved cysteine residues 
(McGeoch, 1990). HSV-1 US6 (gD) contains seven cys- 
teine residues; six appear critical for correct folding, anti- 
genic structure, and extent of oligosaccharide pro- 
cessing (Wilcox et aL, 1988; Long eta/., 1992). Not only 
are these same six cysteines conserved among gD ho- 
mologs of HSV-2 (McGeoch etaL, 1987), PRV (Petrovskis 
eta/., 1986a), EHV-1 (Audonnet eta/., 1990; Flowers et 
al., 1991; Telford eta/., 1992), BHV-1 (Tikoo eta/., 1990), 
and simian herpes B virus (SHBV; Bennett eta/., 1992), 
but they are conserved by the MDV gD homolog as well 
(data not shown). Similar cysteine conservation patterns 
apply to alphaherpesvirus US7 (gl) and US8 (gE) homo- 
logs (McGeoch, 1990) and their MDV counterparts (data 
not shown). 
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MDV SORF2 
FPV ORF4 
83 LEASFHKGQEEL...LEYCEALYLPQPVKMEIVGIVDDVPCLATGMQLLI 129 
== :: :III I=II IIIIII =I:I:I:==I : I:I 
I MDRNINLPEEELKYIKECCEVLYLPQPTRMDIIGVMNDSD.ISWNENLII 49 
MDV SORF2 
FPV ORF4 
130 LVAEGGEVYAYEEDTLHKLATSFSEFLEIGVKSLGREVYHCGEYIEQVVH 179 
I: I=I :I I==: II:I : II III: II IIIII II : 
50 LMSEDGKIYVYDDEALYKVADTMEEFSEIGLINLGNEVYHCREDIKPLPE 99 
FIG. 3. Homology between MDV SORF2 and FPV ORF4. GAP (UWGCG) analysis aligning area conserved between SORF2 and fowlpox virus ORF4 
(Tomley et aL, 1988). Amino acid numbers (with respect to predicted 5' ATG) of aligned sequences are listed at the beginning and end of each 
line. Bars and double dots identify identical and similar amino acid matches, respectively. The area aligned was 67% similar, 42% identical; a FASTA 
score of 237 was obtained. 
Careful inspection of the N-terminal regions of the 
MDV gD, gl, and gE homologs has revealed that all con- 
tain the three basic building blocks of signal peptide 
sequences= a basic, positively charged N-terminal region 
(n-region), a central hydrophobic region (h-region), and 
a more polar terminal region (c-region) that seems to 
define the cleavage site (von Heijne, 1985). Figure 2 
shows the likely position of these sites (von Heijne, 1986). 
Also included are the locations of other characteristic 
features of membrane glycoproteins, namely, the pres- 
ence of potential N-glycosylation sites (i.e., N-X-S/T) and 
putative hydrophobic transmembrane and charged cyto- 
plasmic domains near the C-terminal end. Like other gl- 
homologs, MDV's counterpart contains a relatively long 
cytoplasmic domain. However, in contrast to the other 
gD homologs, MDV gD's signal peptide contains a longer 
n-region (18 residues) that is unusually highly charged 
(+4; Fig. 2) considering an overall mean value of +1.7 
among eukaryotes, which generally does not vary with 
length (von Heijne, 1986). Although a methionine codon 
exists directly before the hydrophobic h-region at posi- 
tion 6997 in Fig. 2 (as in PRV's gD homolog; Petrovskis 
et al., 1986a), the scanning model for translation (Kozak, 
1989) favors usage of the more 5'-proximal initiation co- 
don (at position 6943, Fig. 2). 
Comparison of MDV sequences to those previously 
published 
Comparison of sequences of the "virulent" GA strain 
of MDV (Fig. 2) with those derived from a 5.5-kbp region 
of the "very virulent" RB1B strain of MDV (Ross et aL, 
1991) has revealed over 99% identity at both the nucleic 
acid and the predicted amino acid levels. One difference 
results in an extension of 5 additional amino acids at the 
5' end of the GA US6/gD (M-N-R-Y-R) relative to its RB1B 
sequence counterpart (ORF5; Ross et al., 1991). In addi- 
tion to the 5-AA extension, the next four positions in the 
GA strain (Y-E-S-I) would differ from the corresponding 
RB1B positions (M-K-V-F). Differences in these signal 
sequences could account for differences in gD pro- 
cessing between these two strains. The predicted amino 
acid sequence of the GA US2 (Fig. 2) is identical to that 
published in a recent report (Cantello eta/., 1991), except 
for the presence of an alanine in place of an arginine at 
position 143. This minor difference is due to the inversion 
of a guanine and a cytosine relative to each other in the 
two GA sequences. 
The RB1B counterpart of SORF4 (ORF4 in their report) 
was recently proposed to be a probable homolog of HSV- 
1 gG (Ross and Binns, 1991). It is tempting to propose 
such a homology, given their similar locations relative 
to other Us region genes. We have further tested this 
proposed homology by similarly aligning these two se- 
quences with GAP, following repeated shuffles of either 
of the two sequences while maintaining length and com- 
position (using the/RANdomizations command line op- 
tion for 100 randomizations). This analysis was per- 
formed twice (each time with one of the two sequences 
shuffled). In doing so, we failed to find a significant differ- 
ence in homology score ratios between the actual versus 
randomized alignments (1.12 _+ 0.07). In some cases, 
the homologies of the randomized alignments actually 
exceeded the proposed MDV ORF4/HSV-1 gG alignment. 
Therefore we do not consider the proposed homology to 
be statistically significant. In fact, when using the type 
of stringency in the above example, equally significant 
homologies are encountered with almost any given pro- 
tein database search (data not shown). While we cannot 
absolutely rule out that the two sequences are evolution- 
arily related, any functional homology would appear ab- 
sent, since the supposed MDV gG homolog lacks hy- 
drophobic domains representing signal peptide and 
transmembrane domain regions. Thus, it would appear 
that, at the very least, selection pressure for the mainte- 
nance of a common glycoprotein function appears to 
have been lost in this case. 
DISCUSSION 
New findings 
In this report, we have characterized the sequences 
of 3 new MDV Us region ORFs homologous to HSV US1 
(IOP22), US8 (gE), and US10; 2 new MDV-specific Us 
ORFs (SORF1 and -3); a fowlpox virus homolog (SORF2); 
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and a complete HSV US7-homologous sequence. This 
extends upon the sequence analysis of a 5255-bp seg- 
ment located in the Us region of the RB1B strain (Ross et 
al., 1991; Ross and Binns, 1991). Between two oncogenic 
serotype 1 strains, the "very virulent" RB1 B- and the "viru- 
lent" GA strain, only minor sequence differences were 
found over their common 5.3-kbp region. With completion 
of the entire 11,160-bp Us sequence (GA strain), we have 
precisely determined the IRs-Us and Us-TRs junctions 
(Fig. 2); these were somewhat of a surprise, since previ- 
ous workers (Fukuchi et aL, 1985) using the same MDV 
strain as ours (GA), mapped the IRs-TRs junction to a 
different fragment located 2-3 kb upstream of the correct 
location. 
Alphaherpesvirus S regions are characterized by a set 
of homologs which are specific to members of this taxo- 
nomic subfamily (Davison and Taylor, 1987; McGeoch, 
1990). The identification of seven alphaherpesvirus S re- 
gion homologs in this study is consistent with MDV bear- 
ing a closer relation to alphaherpesviruses than gamma- 
herpesviruses (Buckmaster et aL, 1988). Failure to iden- 
tify CpG dinucleotide deficiencies among MDV Us region 
sequences is further consistent with this proposal (Efs- 
tathiou eta/., 1990; Honess et al., 1989). 
Potential importance of alphaherpesvirus S 
component differences in determining biological 
divergence and pathogenesis 
Since MDV has been traditionally regarded as a gam- 
rnaherpesvirus, much of the previous work interpreting 
MDV's properties has proceeded by analogy with the 
association between EBV and B-cells (Wen et aL, 1988, 
for example). Because of the closer genetic relationship 
between MDV and other alphaherpesviruses, we agree 
with others (Lawrence et al., 1990)that he lymphotropic 
properties of MDVand HVT are unlikely to be determined 
by molecules homologous to those of EBV. 
Upon further examination, more parallels exist be- 
tween the "lymphotropic" MDV and the "neurotropic" 
alphaherpesviruses than previously appreciated. Lymph- 
otropism (and epitheliotropism) is probably common to 
all herpesviruses and is largely responsible for the wide- 
spread dissemination of HSV and VZV in cases involving 
neonatal and immunocompromised patients, often re- 
sulting in death (Nahmias and Roizman, 1973; Grose, 
1982). These infections are characterized by a biphasic 
viremia similar to that observed in MDV-infected chick- 
ens; in the absence of maternal antibodies, young chick- 
ens can often die from an early mortality syndrome lack- 
ing any tumor involvement (Jakowski et al., 1970; Witter 
eta/., 1980). A biphasic viremia has also been estab- 
lished for V-ZV infections involving immunocompetent pa- 
tients as well (Grose, 1981; Ozaki et aL, 1986). With re- 
spect to T-cell tropism, M DV and HSV are similar; replica- 
tion of each is restricted to activated, la-bearing T-cells 
(Braun etaL, 1984; Calnek, 1986). Like MDV, equine her- 
pesvirus-1, an alphaherpesvirus, can also establish la- 
tent infections in T-lymphocytes (Welch eta/., 1992). This 
lends support to an earlier proposal characterizing EHV- 
1 as a T-lymphotropic herpesvirus (Scott et aL, 1989). 
In addition to latent T-lymphocyte infections, MDV also 
appears to establish latent infections in both Schwann 
and satellite cells (Pepose et aL, 1981) like VZV (Croen 
eta/., 1988). Such complexities uggest that a biologically 
based classification system is overly simplistic, poten- 
tially misleading, and guided by biases that are dictated 
by the manner in which these viruses are studied. 
To account for the different biological expressions that 
exist, a renewed focus on molecular differences between 
MDV and other alphaherpesviruses may be in order. In 
this regard, the MDV Us region (and adjoining repeats) 
may be particularly important. Fifty-three of the 55 unique 
long (U,)region genes of HSV-1 possess an equivalent 
in VZV (McGeoch et al., 1988); a considerable number of 
these are related to beta- and gammaherpesvirus genes 
as well (29 of 67 EBV genes are counterparts to VZV Uf 
genes; Davison and Taylor, 1987). In contrast, alphaher- 
pesvirus S components are specific for members of this 
taxonomic subfamily and appear to represent their most 
divergent coding region (Davison and Wilkie, 1983; Davi- 
son and McGeoch, 1986; Telford eta/., 1992). In compar- 
ing MDV with other alphaherpesviruses, significant diver- 
gence also extends to the Urflanking repeat regions 
(Buckmaster et aL, 1988) which are known to be ex- 
pressed in tumor cells (Jones et al., 1992; Schat et al., 
1989; Sugaya et aL, 1991). A comparison of the genetic 
organization of selected alphaherpesvirus S segment 
genes is presented in Fig. 4. It is based on previously 
published reports on EHV-1 Ab4p field isolate strain (Tel- 
ford etaL, 1992), HSV-1 (McGeoch eta/., 1985), VZV (Davi- 
son and Scott, 1986), and PRV (Petrovskis etaL, 1986a,b; 
Petrovskis and Post, 1987; van Zijl et aL, 1990; Zhang 
and Leader, 1990); other alphaherpesvirus S segment 
genes corresponding to BHV-1 (Tikoo et al., 1990); EHV- 
1 Ky-A-cell culture strains (Audonnet eta/., 1990; Breeden 
etaL, 1992; Colle eta/., 1992; Elton eta/., 1991; Flowers 
et al., 1991; Flowers and O'Callaghan, 1992; Holden et 
aL, 1992a,b), EHV-4 (Cullinane et al., 1988; Nagesha et 
al., 1993), HSV-2 (McGeoch et aL, 1987), SHBV (Bennett 
et al., 1992; Killeen et aL, 1992), and simian varicella 
virus (SW; Fletcher and Gray, 1993) have been described 
elsewhere. Despite obvious similarities, there are 
marked differences in (i) gene content, organization, and 
localization; (ii) sequence conservation; and (iii) position- 
ing of IRs-Us and Us-TRs junctions. Nevertheless, these 
overall gene layouts are consistent with a model to ac- 
count for the divergence of alphaherpesviruses from a 
common ancestor by a number of homologous and semi- 
homologous recombination events which result in expan- 
sion or contraction of the inverted repeat regions and a 
concomitant loss or gain of Us gene(s) (Davison and 
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McGeoch, 1986). In the case of VZV, homologs of six 
HSV-1 Us region genes are missing (US2, US4, US5, US6, 
US11, US12). Unlike all other alphaherpesviruses thus 
far analyzed (Fig. 4; Fletcher and Gray, 1993; Killeen et 
al,, 1992), MDV appears to lack a US9 homolog. The 
HSV-1 US9 gene is known to encode a differentially phos- 
phorylated 12- to 20-kDa tegument protein which be- 
comes associated with nucleocapsids at or soon after 
their formation in the nuclei of infected cells (Frame et 
a/., 1986). A recent study has suggested that PRV's US9 
homolog has a function associated with envelopment at 
the nuclear membrane (Pol eta/., 1991). Lacking such a 
homolog might contribute to MDV's characteristic inabil- 
ity to become stably enveloped in tissues other than the 
feather follicle epithelium. 
Presence of MDV-specific and fowlpox virus- 
homologous genes  
MDV contains at least 30RFs unrelated to any others 
presently described (SeRFs 1, -3, and -4; Fig. 4). Other 
S component ORFs have been identified that are specific 
to a given alphaherpesvirus and/or its common-host rela- 
tive. Such genes have been identified in HSV-1/HSV-2 
(US11 and US12; Davison and McGeoch, 1986; McGeoch 
eta/., 1985) and in EHV-1/EHV-4 (ORF67/IR6, ORF 71/ 
EUS4, and ORF 75; Telford eta/., 1992; Colle eta/., 1992; 
Breeden eta/., 1992; Nagesha et aL, 1993). Further se- 
quence analysis of other alphaherpesvirus S regions will 
be necessary to determine whether such genes are truly 
unique to these herpesviruses and whether they confer 
a species-specific growth advantage. 
SERF3, located in the EcoRl-O subfragment (Fig. 1B), 
specifies a 351-AA MDV-specific ORF. Considering its 
location, preliminary transcriptional mapping of the other 
genes mapping in EcoRl-O (e.g., MDV US1 and -10; 
P. Brunovskis, unpublished observations) and previously 
reported data (Schat eta/., 1989), it appears possible that 
SERF3 may code for the 1.1-kb Aj transcript, one of four 
immediate-early transcripts consistently identified in all 
MDV tumor cell lines tested (Schat et a/., 1989). 
A major surprise from this work was finding a FPV- 
related ORF. We are not aware of any other examples of 
such conservation across virus family lines, except a few 
cases that include cellular counterparts as well. MDV's 
FPV homolog, SERF2, was found to be 67% similar and 
42% identical (over 100 AA) to FPV ORF4 (Tomley eta/., 
1988). With a FASTA score of 237 and the alignment in 
Fig..3, the level of conservation is more striking than 
that generally characterizing alphaherpesvirus S region 
homologies (Fig. 4). Interestingly, compared with FPV 
ORF4, SERF2 contains an amino-terminal extension of 
82 AA; conversely, ORF4 carries a carboxy-terminal ex- 
tension of 41 AA. The block of conserved sequences 
may encode one or more functional domains that have 
independently evolved following host cell acquired gene 
transfer. On the other hand, it is intriguing to consider 
the possibility of virus-virus gene transfer. Individual 
cells have been found to besimultaneously infected by 
MDV and FPV (Tripathy et aL, 1975). Given the different 
modes of replication for MDV and FPV (e.g., nuclear vs. 
cytoplasmic) such a possibility could point to a possibly 
novel form of gene transfer. 
MDV Us region genes as potential determinants for 
pathogenesis and tissue tropism 
Recent studies have shown that 11 of 12 open reading 
frames contained in the HSV-1 Us region are dispensable 
for growth in vitro (Longnecker et a/., 1987; Roizman and 
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Sears, 1990). These, and other "dispensable" genes ap- 
pear to specify functions for optimal survival, mainte- 
nance, and dissemination among the host (and its popu- 
lation at large), rather than the presence of functions 
necessary for replication (Longnecker et aL, 1987; Roiz- 
man and Sears, 1990). The significant divergence of 
alphaherpesvirus S components may reflect this region's 
capacity for determining distinct tissue and host cell 
growth potentialities. Previous results have suggested 
that the product of HSV US1 (IOP22) encodes a determi- 
nant for tissue tropism, since its function appears to be 
dispensable for growth in some cell lines, but not others 
(Sears et aL, 1985). Considering the extensive genetic 
divergence among a cluster of different glycoprotein ho- 
mologs, each potentially subject to glycosylation, phos- 
phorylation, palmitylation, myristylation, and/or sulfation 
(Grose, 1990; Spear, 1984), a potentially large window 
exists for the creation of multiply distinct virus-cell inter- 
actions which can affect host range, tissue tropism, inva- 
siveness, and cell-cell spread. Previous results have 
demonstrated that "nonessential" alphaherpesvirus gly- 
coproteins encode functions associated with virulence 
(Lomniczi et al., 1984; Meignier et aL, 1988; Mettenleiter 
eta/., 1988; Roizman and Sears, 1990). This may reflect 
their ability to promote the infection and spread of virus 
in vivo (Lomniczi et aL, 1984; Longnecker et aL, 1987; 
Mettenleiter et aL, 1988; Pol eta/., 1991; Card eta/., 1992). 
Consistent with this proposal is the observation that a 
specific deletion of PRV gl (homolog of HSV gE) and/or 
PRV gp63 (homolog of HSV gl) was found to reduce the 
spread of infection in both rat (Card et al., 1992; Whealy 
eta/., 1993) and pig (Kimman etaL, 1992) central nervous 
systems. This defect could reflect the inability of PRV gl 
mutants to promote cell-cell spread (Zsak eta/., 1992). 
If MDV Us region genes specify virulence determi- 
nants, these could indirectly affect oncogenic potential 
by affecting any number of critical events which precede 
tumor induction. Previous studies have shown that onco- 
genic potential appears to be directly correlated with 
cell-associated viremia levels and the capacity to cause 
immunosuppression (Calnek and Witter, 1991). The se- 
quence of events leading to transformation include (i) an 
initial lytic growth phase in B-cells, which is thought to 
cause activation and expansion of T-cells; (ii) a latent 
growth phase involving infected T-cells; (iii) a second 
wave of iytic infection, coincident with permanent immu- 
nosuppression; and (iv) oncogenic transformation (Cal- 
nek, 1986). Attenuated MDV strains (derived from onco- 
genic serotype 1 strains), as well as nononcogenic MDV 
and HVT stains (serotypes 2 and 3, respectively), are 
deficient in inducing the early cytolytic infection of B- 
cells in chickens, suggesting that their cell tropisms differ 
from those of oncogenic strains (Schat et a/., 1985; Shek 
eta/., 1982). This is reflected in evidence that attenuation 
of MDV leads to a marked reduction in infectivity and/or 
replication in lymphocytes (Schat et a/., 1985). 
In conclusion 
The current herpesvirus classification system has 
been described as "simple, fortuitously appropriate and 
defective" (Roizman, 1990b). It has been further sug- 
gested that "the delineation and evolutionary relatedness 
of genes responsible for biological properties may be a 
more significant criterion for both evolutionary relat- 
edness and classification than the arrangement and evo- 
lution of genes conserved throughout he family Herpes- 
viridae" (Roizman, 1990b, 1992). While such a view is 
currently open to debate, inasmuch as alphaherpesvirus- 
specific Us regions specify a cluster of "dispensable" 
functions thought to be important biological property de- 
terminants, our sequence provides a foundation for fur- 
ther studies to resolve the apparent discrepancy be- 
tween MDV's genetic and biologic properties. 
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Note added in proof. After submission of this paper, we learned of 
an article describing the nucleotide sequence of an 8.9-kb region of 
the MDV GA strain comprising 72% (8020 bp) of the MDV U~ region, 
along with 905 bp of flanking IR~ sequences (Sakaguchi et aL, Virus 
Genes 6(4) 365-378). Their published IRs-Us and Us-TRs junction sites 
were identical to ours. Moreover, their sequence was found to be 99.9% 
identical to ours. However, the few differences that exist presumably 
account for their failure to identify the HSV US1 homolog of MDV and 
the FPV QRF4 homolog (SORF2) in MDV. The US1 error has recently 
been corrected in a published erratum (Virus Genes 7, 109). A missing 
base in their sequence would lead to the premature termination of a 
smaller ORF, with only half of the homology depicted in our Fig. 3. 
Another missing base in their sequence would result in the premature 
termination of the US20RF near amino acid 95. Our US20RF is 
consistent with that of Cantello et al., 1991. Also, recently Zelnick et 
aL {J. Gen. ViroL 74, 2161-2162) described the nucleotide sequence 
and gene organization of MDV's vaccine virus, HVT. HVT was found 
to contain a similar ORF organization, with the exception that it lacks 
MDV SORF1, SQRF2, and SQRF4 homologs. 
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